Location: Home
  • search
  • go
  • Relate News
  • 9/1/2022NMPA and Chinese Customs Announce Addition of Shijiazhuang Airport as ...
  • 8/31/2022Mayo Clinic, Hibiscus and Innoforce Announce Mayflower Cell and Gene T...
  • 8/31/2022Financial-related Company News Digest (August 2022)
  • 8/31/2022IQVIA: Chinese Hospital Drug Market Down 5.8% in Q2/2022
  • 8/31/2022Snapshot of Top Ten Drug Products by Representative Hospital Sales in ...
  • 8/31/2022BCG Report: Chinese Vaccine Sector under Restructure - Opportunities a...
  • 8/30/2022USCBC 2022 Member Survey: China's COVID-19 Policies Are the Top Chall...
  • 8/30/2022CDE Publicizes the List of Reference Formulations for GQCE Studies (62...
  • 8/30/2022CDE Solicits Comments on Draft Technical Guidelines for Writing of Pha...
  • 8/30/2022RoosterBio and MBL Beijing Biotech Partner to Accelerate Advanced Ther...
  • 8/30/2022Noteworthy Drugs Expected To Be Approved in China in H2/2022 (PharmCub...
  • 8/30/2022InnoCare Revs Up For Next Phase With Strong Results, IPO Plan (The Bam...
  • 8/30/2022Henlius CEO Scouts for US PD-1 Partner Amid Fosun Unit's Pivot to Inno...
  • 8/30/2022Drug Discovery in China: A Snapshot of Recent Progress (ScienceDirect)
  • 8/29/2022A Look at the CDE's 2021 Drug Review Report
  • 8/29/2022CDE Solicits Comments on Draft Technical Guidelines for Pharmaceutical...
  • 8/29/2022CDE Issues the List of Reference Formulations for GQCE Studies (57th B...
  • 8/29/2022Porton Advanced, Royaltech Accelerate Development of mRNA Drugs in Chi...
  • 8/26/2022NMPA Announces OTC Switch of Omeprazole Enteric-Coated Tablets
  • 8/26/2022Recent Official and Executive Moves
  • 8/26/2022Drug R&D and Product Registration News Digest August 2022 (4)
  • 8/24/2022Chinese Vaccine Regulatory System Passes New WHO Assessment for ML3 Ra...
  • 8/24/2022NMPA Suspends Import, Sales and Use of UCB's Epilepsy Drug Keppra
  • 8/24/2022Windtree Therapeutics Out-licenses Surfactant Platform in a $79M Globa...
  • 8/24/2022Four Publicly Traded Drugmakers Saw Huge Investments in July
  • 8/23/2022Hansoh Licenses Covid Drug Candidate GDI-4405 from GHDDI
  • 8/22/2022CDE Publishes the Annual Report on Chinese New Drug Registration Clini...
  • 8/22/2022Drug R&D and Approvals in China – July Update on YouTube (PharmCube)
  • 8/22/2022New Rational Drug Use Rules in China Benefit Pediatric, Anti-Tumor And...
  • 8/19/2022An Online Survey of Primary Care Physicians' Knowledge of Common Respi...
  • Page:144/789 Total number of articles:23668: [First][<<] [142] [143] [144] [145] [146] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group